Did InvAscent beat the benchmark in exit from four-year-old pharma bet?
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Did InvAscent beat the benchmark in exit from four-year-old pharma bet?

Did InvAscent beat the benchmark in exit from four-year-old pharma bet?

By Sreeja Biswas

  • 06 Sep 2024
Pro
Did InvAscent beat the benchmark in exit from four-year-old pharma bet?
Hari Buggana, founder, chairman and managing director, InvAscent

Healthcare-focussed private equity firm InvAscent, which is raising its fourth fund and has struck three new deals from ......

New to VCCircle.com?

Subscribe to VCCircle PRO and get privileged access to exclusive curated articles!

Already a VCCircle PRO member? Click here to log in.
Advertisement

Related Articles

Pro
Samara-backed Marengo looks to stitch more hospital acquisitions

Healthcare

Samara-backed Marengo looks to stitch more hospital acquisitions

Premium
Tata Capital's healthcare PE arm marks first close for Fund III

Healthcare

Tata Capital's healthcare PE arm marks first close for Fund III

ChrysCapital inks $159 mn control deal for Novartis India, makes open offer

Healthcare

ChrysCapital inks $159 mn control deal for Novartis India, makes open offer

Premium
Bottomline: PE-controlled Maiva Pharma faces headwinds amid project delays

Healthcare

Bottomline: PE-controlled Maiva Pharma faces headwinds amid project delays

Pro
KKR-backed Healthium in advanced talks for controlling stake in smaller peer

Healthcare

KKR-backed Healthium in advanced talks for controlling stake in smaller peer

Premium
Healthcare RCM firm ACN raises private capital

Healthcare

Healthcare RCM firm ACN raises private capital

Premium
Morgan Stanley PE-backed Sterling Accuris eyes fresh funding, hires banker

Healthcare

Morgan Stanley PE-backed Sterling Accuris eyes fresh funding, hires banker

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW